- Category: HIV Treatment
- Published on Sunday, 13 October 2013 00:00
- Written by Liz Highleyman
The 14th European AIDS Conference, the biennial meeting of the European AIDS Clinical Society (EACS), takes place this week in Brussels. EACS 2013 will immediately follow the 15th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, and will hold joint sessions on the hepatitis C treatment revolution and managing complications such as cardiovascular disease and osteoporosis.
More than 800 abstracts from over 70 countries were submitted and about 3500 participants are expected, according to conference organizers. Some of the highlights will include updated EACS guidelines for antiretroviral therapy (ART), the latest clinical trial results on new antiretroviral drugs, and managing side effects and co-morbidities including HIV/HCV coinfection and tuberculosis.
The EACS 2013 program is available online as well as via a mobile conference app for iPhone or Android. Follow coverage from HIVandHepatitis.com and our content partner Aidsmap.com on our EACS 2013 conference page (coming soon), Facebook page, or via Twitter @HIVandHepatitis and @Aidsmap_news.